BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols

BACKGROUND: Mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) diagnosis is based on cerebrospinal fluid (CSF) or neuroimaging biomarkers. Currently, non-invasive and inexpensive blood-based biomarkers are being investigated, such as neuronal-derived plasma exosomes (NPEs). Neuroinflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Esteban de Antonio, Ester, Pérez-Cordón, Alba, Gil, Silvia, Orellana, Adelina, Cano, Amanda, Alegret, Montserrat, Espinosa, Ana, Alarcón-Martín, Emilio, Valero, Sergi, Martínez, Joan, de Rojas, Itziar, Sotolongo-Grau, Óscar, Martín, Elvira, Vivas, Assumpta, Gomez-Chiari, Marta, Tejero, Miguel Ángel, Bernuz, Mireia, Tárraga, Lluis, Ruiz, Agustín, Marquié, Marta, Boada, Mercè
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543256/
https://www.ncbi.nlm.nih.gov/pubmed/34420953
http://dx.doi.org/10.3233/JAD-210254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543256/
https://www.ncbi.nlm.nih.gov/pubmed/34420953
http://dx.doi.org/10.3233/JAD-210254

Ejemplares similares